BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2017
View Archived Issues
Acorda Therapeutics decides to discontinue tozadenant development program
Read More
Desidustat approved as INN for Zydus Cadila's ZYAN-1
Read More
Lu-AA-41178 demonstrates efficacy in animal models of epilepsy, schizophrenia and depression
Read More
PledPharma and Solasia to develop and commercialize PledOxin Asia
Read More
Aurigene moves oral VISTA/VSIG8 antagonist AUPM-493 towards clinical development
Read More
Starpharma gives update on rolling NDA for VivaGel BV
Read More
FDA accepts, grants priority review to lofexidine NDA
Read More
gamma-Secretase modulator ACD-678 has properties supporting development for Alzheimer's disease
Read More
FDA approves Kaleo's Auvi-Q epinephrine autoinjector
Read More
BMS-986141 prevents arterial thrombosis in monkeys
Read More
Ardelyx discontinues development of RDX-7675
Read More
Catalyst Pharmaceuticals begins phase II proof-of-concept study of Firdapse
Read More
Phase III VITALITY-ALS study of tirasemtiv in ALS does not meet primary endpoint
Read More
Kaken Pharmaceutical evaluates novel prostanoid EP4 receptor antagonist for rheumatoid arthritis
Read More
EMA launches improved version of EudraVigilance system for safety monitoring
Read More
FDA gives orphan drug status to TRM-201 for hemophilic arthropathy
Read More
Immunovaccine and Leidos to develop malaria vaccine candidates
Read More
Janssen submits applications in U.S. and E.U. to expand approval of Darzalex
Read More
Sumitomo Dainippon Pharma and Angelini enter European license and distribution agreement for Latuda
Read More
Columbia University patents anti-RAGE antibodies
Read More
OriMabs presents new anti-PSMA antibodies for prostate cancer
Read More
Spingotec Therapeutics divulges DPP3 inhibitors
Read More
Dosing begins in registrational trial of derazantinib
Read More
Jiangsu MicroMedMark Biotech patents KRAS-targeting siRNAs for cancer
Read More
Menlo Therapeutics begins enrollment in PSORIXA study of serlopitant
Read More
Zebra Biologics and Scripps Research Institute disclose Trk-B agonist antibodies
Read More
Immunoproteasome inhibitor KZR-616 shows promise in phase I study
Read More
BARDA exercises option under Imvamune smallpox vaccine contract
Read More
FDA approves Juluca, the first two-drug regimen for treatment of HIV-1
Read More
